Validated method for the determination of perfluorinated compounds in placental tissue samples based on a simple extraction procedure followed by ultra-high performance liquid chromatography–tandem mass spectrometry analysis

•The analysis of perfluorinated carboxylic acids and perfluorooctane sulfonate is proposed.•A very simple extraction procedure is used for isolation of PFCs from placental tissue.•Box–Behnken experimental design is used for the optimization of d-SPE clean-up step.•UHPLC–MS/MS is used as analytical technique to measure the target compounds.•After validation, the method is applied in 25 samples from randomly selected mothers.

Xenobiotic exposure during pregnancy is inevitable. Determination of perfluorinated compounds (PFCs), chemicals described as environmental contaminants by Public Health Authorities due to their persistence, bioaccumulation and toxicity, is a challenge. In the present work, a method based on a simplified sample treatment involving freeze–drying, solvent extraction and dispersive clean-up of the extracts using C18 sorbents followed by an ultra-high performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) analysis was developed and validated for the determination of five perfluorinated carboxylic acids (C4–C8) and perfluorooctane sulfonate (PFOS) in placental tissue samples. The most influential parameters affecting the extraction method and clean-up were optimized using Design of Experiments (DOE). The method was validated using matrix-matched calibration. Found limits of detection (LODs) ranged from 0.03 to 2 ng g−1 and limits of quantification (LOQs) from 0.08 to 6 ng g−1, while inter- and intra-day variability was under 14% in all cases. Recovery rates for spiked samples ranged from 94% to 113%. The method was satisfactorily applied for the determination of compounds in human placental tissue samples collected at delivery from 25 randomly selected women.

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide